UK Research and Innovation MRC news Update

MRC centre to develop brain stimulation device-based therapies

26-06-2025 04:00 PM BST

The Picostim-DyNeuMo research system, made by UK company Amber Therapeutics, is an adaptive neurostimulator seated in the skull with two electrodes placed in targeted brain circuits to sense physiological signals and provide stimulation.

A new MRC centre aims to develop brain stimulation devices to treat conditions such as Parkinsonâs disease, dementia, stroke and childhood epilepsy.

Help improve our online services

We need your help to improve our online products and services: join UKRI's research panel.

Manage your subscription

Unsubscribe or manage preferences

Contact Us

Connect with us

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com.

This service is provided to you at no charge by UK Research and Innovation.

This email was sent to [email protected] using GovDelivery Communications Cloud, on behalf of: UK Research and InnovationÂ UK Research and Innovation, Polaris House, Swindon, SN2 1FL